Back
Landis+Gyr Group AG Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Sell
27
LGYRF
Landis+Gyr Group AG
Last Price:
$61.32
Seasonality Move:
-0.53%
Buy
57
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$88.46
Seasonality Move:
-32.16%
Sell
27
Landis+Gyr Group AG (LGYRF)
is a Sell
Is Landis+Gyr Group AG a Buy, Sell or Hold?
-
The current Landis+Gyr Group AG [LGYRF] share price is $61.32. The Score for LGYRF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
LGYRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LGYRF Stock Price Chart
What is Landis+Gyr Group AG's stock price today?
-
The Landis+Gyr Group AG share price today is $61.32Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGYRF is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $88.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
LGYRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.23 | Sell |
| Relative Strength Index (14 RSI): | 3.81 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.99 - 73.19) | Sell |
| Bollinger Bands (100): | (60.55 - 77.85) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.77 | Buy |
| Relative Strength Index (14 RSI): | 66.44 | Buy |
| Chaikin Money Flow: | -23974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.51 - 82.89) | Buy |
| Bollinger Bands (100): | (41.26 - 68.88) | Buy |
LGYRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.32 | Sell |
| 20-day SMA: | 62.21 | Sell |
| 50-day SMA: | 72.34 | Sell |
| 200-day SMA: | 65.28 | Sell |
| 8-day EMA: | 61.47 | Sell |
| 20-day EMA: | 63.94 | Sell |
| 50-day EMA: | 68.21 | Sell |
| 200-day EMA: | 68.75 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.48 | Buy |
| 20-day SMA: | 74.4 | Buy |
| 50-day SMA: | 65.57 | Buy |
| 200-day SMA: | 42.82 | Buy |
| 8-day EMA: | 85.2 | Buy |
| 20-day EMA: | 77.09 | Buy |
| 50-day EMA: | 66.93 | Buy |
| 200-day EMA: | 47.3 | Buy |
Landis+Gyr Group AG Earnings Growth & LGYRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Landis+Gyr Group AG Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||